Krka Maintains Positive Outlook

On the back of impressive 2006 financial results, Slovenian drugmaker Krka is looking to further penetrate emerging markets, continue to upscale its R&D capabilities, get more products approved and invest in infrastructure to ensure future growth.

To read the full article, please take a trial.